🇺🇸 FDA
Patent

US 10202340

Glucosylceramide synthase inhibitors and therapeutic methods using the same

granted A61KA61K31/4015A61P

Quick answer

US patent 10202340 (Glucosylceramide synthase inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4015, A61P, A61P13/12, A61P17/00